Tenaya Therapeutics, Inc.

TNYA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001858848

Price chart

Open-market purchases and sales by TNYA insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Aug 17, 20268:50 PM ETAug 17, 2026Ali FarazChief Executive OfficerSSaleCommon Stock−22.23K$0.7097−$15.78K417.78K−5.1%SEC
Aug 17, 20268:49 PM ETAug 17, 2026Tingley WhittemoreChief Medical OfficerSSaleCommon Stock−7.42K$0.7098−$5.27K214.07K−3.4%SEC
May 19, 2026May 18, 2026Ali FarazChief Executive OfficerSSaleCommon Stock−3.39K$0.79−$2.68K440.01K−0.8%SEC
May 19, 2026May 18, 2026Tingley WhittemoreChief Medical OfficerSSaleCommon Stock−3.12K$0.79−$2.47K215.5K−1.4%SEC
May 19, 2026May 18, 2026Higa TomohiroSVP, FinanceSSaleCommon Stock−1.49K$0.79−$1.17K118.27K−1.2%SEC

The largest institutional positions in TNYA at the end of Q2 2026.

Institutions holding TNYA in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
VANGUARD CAPITAL MANAGEMENT LLC7,101,263$5.25M0.00%−1,381,025−16.3%Reduced
MILLENNIUM MANAGEMENT LLC6,429,648$4.75M0.00%+972,982+17.8%Added
CITADEL ADVISORS LLC4,566,774$3.38M0.00%+366,774+8.7%Added
RENAISSANCE TECHNOLOGIES LLC4,281,100$3.16M0.00%+567,339+15.3%Added
BlackRock, Inc.4,008,719$2.96M0.00%+304,764+8.2%Added